Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Ab Biodisk — Predicate Candidate Screening

64 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

78 daysmedian FDA review time
123 days90th percentile
64clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K081325ETEST DORIPENEM - ANTIMICROBIAL SUSCEPTIBILITY TEST - MIC ATAb Biodisk2008-07-24731
K052366ETEST TIGECYCLINE GRAM POSITIVE AND GRAM NEGATIVE AEROBIC BAAb Biodisk2005-10-13450
K042392DAPTOMYCINAb Biodisk2004-12-131020
K042390ETEST FOR GEMIFLOXACINAb Biodisk2004-11-19780
K040560ETEST FOR ANTIFUNGAL SUSCEPTTIBILITY TESTINGAb Biodisk2004-07-271461
K021445ETEST CEFDITOREN FOR S. PNEUMONIAE AND H. INFLUENZAEAb Biodisk2002-06-06310
K020748ETEST ERTAPENEMAb Biodisk2002-04-29532
K010363ETEST MEROPENEMAb Biodisk2001-04-09612
K002139ETEST LINEZOLIDAb Biodisk2000-11-081140
K001547ETEST ESBL CT/CTL STRIP; ETEST ESBL TZ/TZL STRIPAb Biodisk2000-08-07810
K000596ETEST GATIFLOXACINAb Biodisk2000-05-22900
K000298ETEST MOXIFLOXACINAb Biodisk2000-05-181080
K992993ETEST FOR QUINUPRISTIN/DALFOPRISTINAb Biodisk1999-11-16700
K990722ETEST FOR CEFUROXIMEAb Biodisk1999-04-22480
K990685TRIMETHOPRIM/SULPHAMETHOXAZOLE (1/19)Ab Biodisk1999-03-26230
K990297ETEST MINOCYCLINEAb Biodisk1999-03-22521
K984491SYSTEM U3 FOR CEFUROXIMEAb Biodisk1999-03-09820
K984581SYSTEM U3 FOR CEPHALOTHINAb Biodisk1999-03-09760
K983890SYSTEM U3Ab Biodisk1999-02-181080
K984144SYSTEM U3 FOR AMOXICILLIN/CLAVULANIC ACIDAb Biodisk1999-02-09830
K984087SYSTEM U3 FOR AMPICILLINAb Biodisk1999-02-08840
K983565SYSTEM U3 FOR NITROFURANTOINAb Biodisk1999-01-05840
K983571SYSTEM U3 FOR TETRACYCLINEAb Biodisk1998-12-30780
K983486SYSTEM U3 FOR NORFLOXACINAb Biodisk1998-12-23790
K983259SYSTEM U3 FOR TRIMETHOPRIM/SULFAMETHOXAZOLEAb Biodisk1998-11-25700
K983027TRIMETHOPRIM/SULPHAMETHOXAZOLEAb Biodisk1998-10-02320
K982868ETEST RIFAMPICIN WITH INDICATIONS FOR S. PNEUMONIAEAb Biodisk1998-09-30471
K981639SYSTEM U3 FOR CIPROFLOXACINAb Biodisk1998-09-031180
K980877ETEST CEFDINIRAb Biodisk1998-07-061190
K980335ETEST BENZYLPENICILLINAb Biodisk1998-06-151380
K981135ETEST BENZYLPENICILLINAb Biodisk1998-06-09712
K981137ETEST CEFOTAXIMEAb Biodisk1998-06-09711
K981136ETEST FOSFOMYCINAb Biodisk1998-06-09711
K981138ETEST CIPROFLOXACINAb Biodisk1998-06-05671
K981139ETEST CEFTRIAXONEAb Biodisk1998-06-01631
K980342ETEST CHLORAMPHENICALAb Biodisk1998-05-291210
K980348ETEST VANCOMYCINAb Biodisk1998-05-291213
K981134ETEST TETRACYCLINEAb Biodisk1998-05-28590
K980338ETEST OFLOXACINAb Biodisk1998-05-281200
K980347ETEST TETRACYCLINEAb Biodisk1998-05-271190
K980345ETEST CEFTRIAXONEAb Biodisk1998-05-271182
K980773ETEST GREPAFLOXACINAb Biodisk1998-05-18770
K980603ETEST TROVAFLOXACINAb Biodisk1998-05-13850
K971697ETEST FOR LEVOFLOXACINAb Biodisk1997-07-14671
K971694ETEST FOR CEFTAZIDIMEAb Biodisk1997-06-30541
K970473ETEST SUBMISSION FOR AZITHROMYCIN/S. PNEUMONIAEAb Biodisk1997-05-01830
K964236(MODIFIED) ETEST PACKAGE INSERTAb Biodisk1997-05-011950
K970210AMIKACINAb Biodisk1997-05-011001
K970820ETEST SPARFLOXACINAb Biodisk1997-04-25500
K964203PIPERACILLIN/TAZOBACTAM 4Ab Biodisk1996-12-18770

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda